Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06736691 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Study acronym: TREMO-Pemba
StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Swiss Tropical & Public Health Institute to Swiss Tropical & Public Health Institute Trial completed · Secondary endpoints: details revised at 1 of 2 entries · Publications: details revised at 2 of 2 entries · 1 more Show 4 more changesShow less
    • Trial completed
    • Secondary endpoints: details revised at 1 of 2 entries
    • Publications: details revised at 2 of 2 entries
    • Eligibility criteria expanded, about 5 words
  2. Trial status changed: Enrolling by Invitation → Active, Not Recruiting Primary completion date changed from estimate of Jul 2026 to Jul 1, 2026 · Completion date: Oct 2026 to Sep 16, 2026 · Collaborators: 3 to 4v9 Show 3 more changesShow less
    • Primary completion date changed from estimate of Jul 2026 to Jul 1, 2026
    • Completion date: Oct 2026 to Sep 16, 2026
    • Collaborators: 3 to 4

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion pushed from May 2026 to Jul 2026 Completion pushed from Jul 2026 to Oct 2026v8 Show 1 more changeShow less
    • Completion pushed from Jul 2026 to Oct 2026
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation Primary completion date: Feb 2026 to May 2026 · Completion date: Apr 2026 to Jul 2026 · Start date changed from estimate of Oct 2025 to Nov 25, 2025 · 2 morev7 Show 5 more changesShow less
    • Primary completion date: Feb 2026 to May 2026
    • Completion date: Apr 2026 to Jul 2026
    • Start date changed from estimate of Oct 2025 to Nov 25, 2025
    • Eligibility criteria shortened, about 9 words
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: May 2025 to Oct 2025 Primary completion date: Sep 2025 to Feb 2026 · Completion date: Nov 2025 to Apr 2026 · Eligibility criteria expanded, about 8 wordsv6 Show 3 more changesShow less
    • Primary completion date: Sep 2025 to Feb 2026
    • Completion date: Nov 2025 to Apr 2026
    • Eligibility criteria expanded, about 8 words

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Eligibility criteria shortened, about 25 wordsv5 See this version in full on ClinicalTrials.gov ↗
  2. 3 versions Re-verified since Dec 16, 2024, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to assess the efficacy and safety of emodepside compared to mebendazole in adults and adolescents infected with T. trichiura, either as single infection or co-infections with hookworm and/or A. lumbricoides.
Trial Details
NCT Number NCT06736691
Lead Sponsor Swiss Tropical & Public Health Institute
Collaborators: Public Health Laboratory Ivo de Carneri, Bayer, Coefficient Giving, Ifakara Health Institute
Conditions Trichuris Trichiura; Infection, Hookworm Infection, Ascaris Lumbricoides Infection
Enrollment 315 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov